QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine

Conditions:   Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent Interventions:   Biological: ALT-803;   Biological: ETBX-011;   Biological: GI-4000;   Biological: haNK for infusion;   Biological: avelumab;   Drug: Capecitabine;   Drug: Cyclophosphamide;   Drug: 5-Fluorouracil;   Drug: Leucovorin;   Drug: nab-Paclitaxel;   Drug: Sorafenib;   Procedure:  SBRT;   Biological: Aldoxorubicin hydrochloride;   Biological: ETBX-051;   Biological: ETBX-061;   Biological: GI-6207;   Biological: GI-6301;   Drug: Cetuximab Sponsor:   NantKwest, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials